日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes

美国2型糖尿病退伍军人中新发非动脉炎性前部缺血性视神经病变和索马鲁肽起始治疗

Heberer, Kent; Bress, Adam P; Cogill, Steven; Maldonado, Ana I; Kim, Sun H; Nallamshetty, Shriram; Chen, Ying Q; Shih, Mei-Chiung; Lynch, Julie A; Lee, Jennifer S

Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction

基于基因组学的药物重定位策略确定了两个可用于预防与代谢功能障碍相关的肝脏疾病的治疗靶点

Seagle, Hannah M; Akerele, Alexis T; DeCorte, Joseph A; Hellwege, Jacklyn N; Breeyear, Joseph H; Kim, Jeewoo; Levin, Michael G; Khodursky, Samuel; Bress, Adam; Lee, Kyung Min; Meiler, Jens; Gill, Dipender; Lee, Jennifer S; Heberer, Kent; Miller, Donald R; Reaven, Peter D; Chang, Kyong-Mi; Lynch, Julie A; Khankari, Nikhil K; Shuey, Megan M; Edwards, Todd L; Vujkovic, Marijana

Desymmetrization of Bisallylic Amides: A Catalytic Enantioselective Diastereoselective Chlorocyclization Strategy

双烯丙基酰胺的去对称化:一种催化对映选择性非对映选择性氯环化策略

Yi, Yi; Chakraborty, Ankush; Ding, Xinliang; Jaganathan, Arvind; Heberer, Neil; Borhan, Babak

Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany

设计整合式早期临床试验方案以减少重大修改,包括考虑患者群体——德国多方利益相关者就切实可行的方案达成共识

Schultz-Heienbrok, R; Baumann, S; Böhm, R; Bonertz, A; Breithaupt-Groegler, K; Buckpesch-Heberer, U; Coenen, M; Erb-Zohar, K; Faisst, N; Grass, G; Höchel, J; Kovar, A; Muehlenbroich, A; Rengelshausen, J; Riedel, C; Schug, B; Sudhop, T; Warnke, A; Ziegele, B

Comparing Single-Hospital and National Models to Predict 30-Day Inpatient Mortality

比较单院模型和全国模型预测30天住院死亡率

Cogill, Steven; Heberer, Kent; Kaushal, Amit; Fang, Daniel; Lee, Jennifer

[Oncological operation reports: minimum requirements, legal aspects and future developments]

【肿瘤手术报告:最低要求、法律方面及未来发展】

Klose, Johannes; Böhm, Sandra; Bruns, Christiane J; Chojecki, Paul; Conradi, Lena-Christin; Fichtner-Feigl, Stefan; Grützmann, Robert; Heberer, Jörg; Jansen-Winkeln, Boris; Jakob, Jens; Kohlhaw, Kay; Oehme, Astrid; Ronellenfitsch, Ulrich; Roth, Susanne; Rüger, Christoph; Sauer, Igor; Schulz, Harald; Zehnder, Sven; Kleeff, Jörg

Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease

基于基因组学的药物重定位策略揭示了代谢功能障碍相关脂肪肝疾病的新治疗靶点

Seagle, Hannah M; Akerele, Alexis T; DeCorte, Joseph A; Hellwege, Jacklyn N; Breeyear, Joseph H; Kim, Jeewoo; Levin, Michael; Khodurksy, Samuel; Bress, Adam; Lee, Kyung; Meiler, Jens; Gill, Dipender; Lee, Jennifer S; Heberer, Kent; Miller, Donald R; Reaven, Peter; Chang, Kyong-Mi; Lynch, Julie A; Khankari, Nikhil K; Shuey, Megan M; Edwards, Todd L; Vujkovic, Marijana

Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning

利用机器学习预测 SARS-CoV-2 感染在 Omicron 疫情期间的临床结果

Cogill, Steven; Nallamshetty, Shriram; Fullenkamp, Natalie; Heberer, Kent; Lynch, Julie; Lee, Kyung Min; Aslan, Mihaela; Shih, Mei-Chiung; Lee, Jennifer S

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

利用电子健康记录构建基因支持的糖尿病药物再利用流程

Shuey, Megan M; Lee, Kyung Min; Keaton, Jacob; Khankari, Nikhil K; Breeyear, Joseph H; Walker, Venexia M; Miller, Donald R; Heberer, Kent R; Reaven, Peter D; Clarke, Shoa L; Lee, Jennifer; Lynch, Julie A; Vujkovic, Marijana; Edwards, Todd L

Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

利用孟德尔随机化方法,通过重新利用用于血脂管理的药物,寻找预防2型糖尿病的机会。

Khankari, Nikhil K; Keaton, Jacob M; Walker, Venexia M; Lee, Kyung Min; Shuey, Megan M; Clarke, Shoa L; Heberer, Kent R; Miller, Donald R; Reaven, Peter D; Lynch, Julie A; Vujkovic, Marijana; Edwards, Todd L